CORT |
Corcept Therapeutics Incorporated |
6.40B |
5.47% |
|
|
|
|
|
61.11 |
10.49% |
60.98% |
27.26% |
---|
BMY |
Bristol-Myers Squibb Company |
115.69B |
4.38% |
|
|
|
|
|
57.04 |
1.33% |
26.07% |
39.82% |
---|
ITCI |
Intra-Cellular Therapies, Inc. |
13.44B |
4.32% |
|
|
|
|
|
126.50 |
0.24% |
12.02% |
5.91% |
---|
JAZZ |
Jazz Pharmaceuticals plc |
7.34B |
4.22% |
|
|
|
|
|
121.43 |
0.21% |
27.41% |
17.79% |
---|
VTRS |
Viatris Inc. |
13.52B |
4.04% |
|
|
|
|
|
11.33 |
0.27% |
27.64% |
37.90% |
---|
CTLT |
CATALENT INC |
|
4.00% |
|
|
|
|
|
|
|
|
|
---|
AXSM |
Axsome Therapeutics, Inc. |
4.66B |
3.72% |
|
|
|
|
|
96.18 |
4.62% |
44.47% |
15.98% |
---|
PRGO |
Perrigo Company plc |
3.34B |
3.57% |
|
|
|
|
|
24.45 |
2.56% |
38.19% |
31.86% |
---|
TARS |
Tarsus Pharmaceuticals, Inc. |
1.79B |
3.48% |
|
|
|
|
|
46.74 |
0.47% |
82.26% |
27.51% |
---|
EWTX |
Edgewise Therapeutics, Inc. |
2.59B |
3.46% |
|
|
|
|
|
27.39 |
4.30% |
97.34% |
21.37% |
---|
RPRX |
Royalty Pharma plc |
13.46B |
3.39% |
|
|
|
|
|
30.30 |
-1.46% |
26.06% |
13.15% |
---|
PFE |
Pfizer Inc. |
150.97B |
3.38% |
|
|
|
|
|
26.64 |
1.29% |
28.29% |
56.47% |
---|
ZTS |
Zoetis Inc. |
75.58B |
3.34% |
|
|
|
|
|
167.53 |
1.29% |
29.50% |
31.91% |
---|
JNJ |
Johnson & Johnson |
356.69B |
3.31% |
|
|
|
|
|
148.15 |
0.76% |
19.03% |
41.70% |
---|
MRK |
Merck & Co., Inc. |
243.45B |
3.24% |
|
|
|
|
|
96.24 |
-1.72% |
29.23% |
82.06% |
---|
ELAN |
Elanco Animal Health Incorporated |
5.95B |
3.20% |
|
|
|
|
|
12.04 |
0.17% |
40.52% |
22.03% |
---|
LLY |
Eli Lilly and Company |
704.72B |
3.18% |
|
|
|
|
|
742.35 |
2.29% |
36.06% |
35.13% |
---|
OGN |
Organon & Co. |
4.09B |
2.69% |
|
|
|
|
|
15.88 |
0.89% |
41.95% |
41.92% |
---|
PBH |
Prestige Consumer Healthcare Inc. |
3.92B |
2.65% |
|
|
|
|
|
79.30 |
0.92% |
34.44% |
40.54% |
---|
PCRX |
Pacira BioSciences, Inc. |
1.05B |
2.53% |
|
|
|
|
|
22.84 |
2.15% |
61.69% |
17.42% |
---|
SUPN |
Supernus Pharmaceuticals, Inc. |
2.13B |
2.36% |
|
|
|
|
|
38.58 |
2.23% |
46.15% |
46.09% |
---|
ARVN |
Arvinas, Inc. |
1.28B |
2.11% |
|
|
|
|
|
18.57 |
2.88% |
130.54% |
96.05% |
---|
LGND |
Ligand Pharmaceuticals Incorporated |
2.22B |
2.01% |
|
|
|
|
|
117.36 |
4.89% |
51.24% |
47.66% |
---|
AMPH |
Amphastar Pharmaceuticals, Inc. |
1.73B |
1.99% |
|
|
|
|
|
36.03 |
0.92% |
46.25% |
26.50% |
---|
COLL |
Collegium Pharmaceutical, Inc. |
1.07B |
1.66% |
|
|
|
|
|
33.19 |
-0.48% |
121.06% |
60.78% |
---|
ANIP |
ANI Pharmaceuticals, Inc. |
1.23B |
1.59% |
|
|
|
|
|
58.35 |
-0.19% |
32.70% |
32.75% |
---|
OCUL |
Ocular Therapeutix, Inc. |
1.27B |
1.44% |
|
|
|
|
|
8.09 |
1.00% |
144.64% |
61.01% |
---|
HRMY |
Harmony Biosciences Holdings, Inc. |
2.31B |
1.35% |
|
|
|
|
|
40.46 |
3.61% |
67.35% |
53.67% |
---|
AMRX |
Amneal Pharmaceuticals, Inc. |
3.95B |
1.32% |
|
|
|
|
|
8.56 |
3.63% |
182.91% |
18.97% |
---|
FULC |
Fulcrum Therapeutics, Inc. |
215.75M |
1.25% |
|
|
|
|
|
4.00 |
1.01% |
186.02% |
28.96% |
---|
WVE |
Wave Life Sciences Ltd. |
1.69B |
1.22% |
|
|
|
|
|
11.10 |
1.00% |
90.42% |
7.01% |
---|
MNMD |
Mind Medicine (MindMed) Inc. |
526.52M |
1.18% |
|
|
|
|
|
7.18 |
0.35% |
95.37% |
34.06% |
---|
LQDA |
Liquidia Corporation |
1.15B |
1.09% |
|
|
|
|
|
13.62 |
5.66% |
62.92% |
8.77% |
---|
PLRX |
Pliant Therapeutics, Inc. |
673.65M |
1.06% |
|
|
|
|
|
11.07 |
-1.25% |
117.45% |
71.52% |
---|
HROW |
Harrow Health, Inc. |
1.29B |
1.03% |
|
|
|
|
|
36.10 |
6.65% |
72.41% |
13.50% |
---|
INVA |
Innoviva, Inc. |
1.17B |
1.02% |
|
|
|
|
|
18.75 |
0.92% |
166.79% |
68.37% |
---|
NMRA |
Neumora Therapeutics, Inc. Common Stock |
332.82M |
0.82% |
|
|
|
|
|
2.0600 |
0.49% |
80.17% |
12.95% |
---|
EYPT |
EyePoint Pharmaceuticals, Inc. |
520.76M |
0.79% |
|
|
|
|
|
7.63 |
2.01% |
131.77% |
31.50% |
---|
ELVN |
Enliven Therapeutics, Inc. |
1.07B |
0.67% |
|
|
|
|
|
22.00 |
2.47% |
111.79% |
10.89% |
---|
NUVB |
Nuvation Bio Inc. |
868.34M |
0.64% |
|
|
|
|
|
2.5800 |
2.79% |
341.70% |
20.04% |
---|
EOLS |
Evolus, Inc. |
853.57M |
0.56% |
|
|
|
|
|
13.48 |
28.26% |
70.08% |
34.19% |
---|
XERS |
Xeris Biopharma Holdings, Inc. |
497.93M |
0.56% |
|
|
|
|
|
3.34 |
4.38% |
175.48% |
80.84% |
---|
PHAT |
Phathom Pharmaceuticals, Inc. |
464.28M |
0.49% |
|
|
|
|
|
6.79 |
-2.44% |
141.02% |
28.74% |
---|
SAVA |
Cassava Sciences, Inc. |
126.05M |
0.28% |
|
|
|
|
|
2.6200 |
-4.73% |
96.38% |
10.96% |
---|
|
SSI US GOV MONEY MARKET CLASS |
|
N/A |
|
|
|
|
|
|
|
|
|
---|